The story of Sildenafil presents a intricate picture for shareholders. While the initial launch generated substantial profits, the lapse of its patent opened the door to generic competitors, dramatically diminishing https://baidubookmark.com/story21474664/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet